In summary, our results suggest that MAEL plays a critical role in driving HCC stemness via PTGS2/Akt/NF-κb/IL8 signaling and subsequently promotes self-renewal and drug-resistant phenotypes. Here, NFKB1 is linked to hepatocellular carcinoma.